Big Data Pharma Companies Production Regulation 
pharmaphorum
JULY 14, 2022
A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.
Drug Discovery World
FEBRUARY 6, 2024
Technologies like artificial intelligence (AI), machine learning (ML) and robotics/automation are enabling researchers to process enormous data sets and conduct preclinical investigations in record time, speeding up the process and offering greater accuracy. Universities are also using these digital technologies to advance their research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 16, 2021
They had to be nurtured and cared for, despite the fact we, as pharma companies, have very limited direct access to patients. Historically, marketing excellence has been very product-driven. We need to love our customers more than our products and place their safety and interests above everything else.
Pharma Marketing Network
JUNE 11, 2020
MM&M covers the news and happenings in the agency world and pharma marketing world Med Ad News focused on the agency side and a lot of great awards. PM360 is the go-to when it comes to the product manager and the, how-to manual, if you will, for product managers. Big Data was a critical topic.
pharmaphorum
DECEMBER 22, 2021
The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?
Expert insights. Personalized for you.
52 
Let's personalize your content